Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–14 of 14 results
Advanced filters: Author: Joe Alper Clear advanced filters

  • After many fits and starts, European biotechnology is finally gaining steam, despite institutional and cultural obstacles facing would-be entrepreneurs, says Joe Alper.

    • Joe Alper
    Comments & Opinion
    Nature Biotechnology
    Volume: 20, P: BE3-BE5

  • Do it yourself 'biohackers' want to break down institutional barriers and bring science to the people. But good intentions are up against the hard realities of doing science. Joe Alper reports, with additional reporting by Laura DeFrancesco.

    • Joe Alper
    News
    Nature Biotechnology
    Volume: 27, P: 1077-1078

  • A diverse, multidisciplinary panel of 386 experts in COVID-19 response from 112 countries provides health and social policy actions to address inadequacies in the pandemic response and help to bring this public health threat to an end.

    • Jeffrey V. Lazarus
    • Diana Romero
    • Anne Øvrehus
    ResearchOpen Access
    Nature
    Volume: 611, P: 332-345

  • Agios has brought cancer metabolism into vogue and is making hay from tumor cells' well-known hunger for glucose.

    • Joe Alper
    • Lisa Melton
    News
    Nature Biotechnology
    Volume: 28, P: 639

  • As a result, regulatory approval of new cancer products may speed up.

    • Joe Alper
    News
    Nature Biotechnology
    Volume: 22, P: 1335-1336

  • Fred Kavli is a visionary philanthropist who began selling wood briquettes in wartime Norway and is now investing his fortune in keeping blue-sky research alive.

    • Joe Alper
    News
    Nature Biotechnology
    Volume: 26, P: 600

  • Biotech companies at this US facility expect to benefit when researchers and clinicians move in and open up research labs and hospitals.

    • Joe Alper
    Comments & Opinion
    Bioentrepreneur
    P: 1-2

  • Cindy Robbins-Roth, long a force in biotech publishing and consulting, reflects on her self-adopted mission to both nurture the growth of biotechnology and bring a little fun to the field.

    • Joe Alper
    Comments & Opinion
    Bioentrepreneur
    P: 1-3

  • Who are the super financiers of biotechnology?

    • Joe Alper
    Comments & Opinion
    Bioentrepreneur
    P: 1-5